source
- Endpoints AI Day highlights agents, AI slop and biosecurity gaps in pharmaEndpoints News held its third AI Day, an event dedicated to exploring how artificial intelligence can be applied across drug discovery and development. Speakers, including Nathan Frey of Anthropic…
- Pharma companies push FDA for risk-based flexibility in container-closure testing guidanceMajor pharma firms have written to the FDA urging a shift in its current guidance on testing container-closure systems for drug and biologic products. They argue that a risk-based, flexible approa…